Pharmaceutical Contract Manufacturing Market To Surpass USD 279.3 Billion By 2032 At A CAGR Of 6.8%
The report analyzes and forecasts the Pharmaceutical Contract Manufacturing Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Pharmaceutical Contract Manufacturing Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Pharmaceutical Contract Manufacturing Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Pharmaceutical Contract Manufacturing Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/353
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Some of the top pharmaceutical contract manufacturing market companies offered in the professional report includes Lonza Group AG, Catalent, Inc., Thermo Fisher Scientific Inc., Patheon N.V., Evonik Industries AG, AbbVie Contract Manufacturing, Boehringer Ingelheim GmbH, Recipharm AB, Jubilant Life Sciences Limited, and Dr. Reddy’s Laboratories Ltd.
The major market segments of Pharmaceutical Contract Manufacturing Market are as below:
Pharmaceutical Contract Manufacturing Market By Services
- Pharmaceutical Manufacturing Services
- Pharmaceutical FDF Manufacturing Services
- Tablet manufacturing services
- Parenteral/injectable manufacturing services
- Capsule manufacturing services
- Semi-solid manufacturing services
- Oral liquid manufacturing services
- Other formulation manufacturing services
- Pharmaceutical API Manufacturing Services
- Pharmaceutical FDF Manufacturing Services
- Biologics Manufacturing Services
- Biologics FDF Manufacturing Services
- Biologics API Manufacturing Services
- Drug Development Services
Pharmaceutical Contract Manufacturing Market By End-user
- Big Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Small & Medium-sized Pharmaceutical Companies
- Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Pharmaceutical Contract Manufacturing Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Contract Manufacturing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Contract Manufacturing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Contract Manufacturing Market By Services
1.2.3. Pharmaceutical Contract Manufacturing Market By End-user
1.2.4. Pharmaceutical Contract Manufacturing Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-user
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Contract Manufacturing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Contract Manufacturing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Materials
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Pharmaceutical Contract Manufacturing Market By Services
5.1. Introduction
5.2. Pharmaceutical Contract Manufacturing Revenue By Services
5.2.1. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast, By Services, 2020-2032
5.2.2. Pharmaceutical Manufacturing Services
5.2.2.1. Pharmaceutical Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Pharmaceutical API Manufacturing Services
5.2.2.2.1. Pharmaceutical API Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Pharmaceutical FDF Manufacturing Services
5.2.2.3.1. Pharmaceutical FDF Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.2. Tablet manufacturing services
5.2.2.3.2.1. Tablet manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.3. Parenteral/injectable manufacturing services
5.2.2.3.3.1. Parenteral/injectable manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.4. Capsule manufacturing services
5.2.2.3.4.1. Capsule manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.5. Semi-solid manufacturing services
5.2.2.3.5.1. Semi-solid manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.6. Oral liquid manufacturing services
5.2.2.3.6.1. Oral liquid manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3.7. Other formulation manufacturing services
5.2.2.3.7.1. Other formulation manufacturing services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Drug Development Services
5.2.3.1. Drug Development Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Biologics Manufacturing Services
5.2.4.1. Biologics Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4.2. Biologics API Manufacturing Services
5.2.4.2.1. Biologics API Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4.3. Biologics FDF Manufacturing Services
5.2.4.3.1. Biologics FDF Manufacturing Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pharmaceutical Contract Manufacturing Market By End-user
6.1. Introduction
6.2. Pharmaceutical Contract Manufacturing Revenue By End-user
6.2.1. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast, By End-user, 2020-2032
6.2.2. Big Pharmaceutical Companies
6.2.2.1. Big Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Generic Pharmaceutical Companies
6.2.3.1. Generic Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Small & Medium-sized Pharmaceutical Companies
6.2.4.1. Small & Medium-sized Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Pharmaceutical Contract Manufacturing Market By Country
7.1. North America Pharmaceutical Contract Manufacturing Market Overview
7.2. U.S.
7.2.1. U.S. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
7.2.2. U.S. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
7.3. Canada
7.3.1. Canada Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
7.3.2. Canada Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Pharmaceutical Contract Manufacturing Market By Country
8.1. Europe Pharmaceutical Contract Manufacturing Market Overview
8.2. U.K.
8.2.1. U.K. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
8.2.2. U.K. Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.3. Germany
8.3.1. Germany Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
8.3.2. Germany Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.4. France
8.4.1. France Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
8.4.2. France Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.5. Spain
8.5.1. Spain Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
8.5.2. Spain Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
8.6.2. Rest of Europe Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Pharmaceutical Contract Manufacturing Market By Country
9.1. Asia Pacific Pharmaceutical Contract Manufacturing Market Overview
9.2. China
9.2.1. China Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.2.2. China Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.3. Japan
9.3.1. Japan Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.3.2. Japan Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.4. India
9.4.1. India Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.4.2. India Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.5. Australia
9.5.1. Australia Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.5.2. Australia Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.6. South Korea
9.6.1. South Korea Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.6.2. South Korea Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
9.7.2. Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Pharmaceutical Contract Manufacturing Market By Country
10.1. Latin America Pharmaceutical Contract Manufacturing Market Overview
10.2. Brazil
10.2.1. Brazil Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
10.2.2. Brazil Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.3. Mexico
10.3.1. Mexico Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
10.3.2. Mexico Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
10.4.2. Rest of Latin America Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Pharmaceutical Contract Manufacturing Market By Country
11.1. Middle East & Africa Pharmaceutical Contract Manufacturing Market Overview
11.2. GCC
11.2.1. GCC Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
11.2.2. GCC Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.3. South Africa
11.3.1. South Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
11.3.2. South Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By Services, 2020-2032
11.4.2. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Pharmaceutical Contract Manufacturing Market
12.1. Pharmaceutical Contract Manufacturing Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Pharmaceutical Contract Manufacturing Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Lonza Group AG
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. Lonza Group AG 2022 Pharmaceutical Contract Manufacturing Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Catalent, Inc.
13.3. Thermo Fisher Scientific Inc.
13.4. Patheon N.V.
13.5. Evonik Industries AG
13.6. AbbVie Contract Manufacturing
13.7. Boehringer Ingelheim GmbH
13.8. Recipharm AB
13.9. Jubilant Life Sciences Limited
13.10. Dr. Reddy’s Laboratories Ltd.
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/353
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
